Orbimed ROF II LLC insider trades: Xtant Medical Holdings (XTNT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Orbimed ROF II LLC reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 10, 2025 | XTNT | ↓ Sell | 73,114,592 | $0.42 | $30.7M | Indirect | Apr 14, 2025 (4d) |
| Jul 19, 2021 | AFIB | ↑ Buy | 1,071,428 | $14.00 | $15.0M | Indirect | Jul 21, 2021 (2d) |
| Aug 10, 2020 | AFIB | ↑ Buy | 415,000 | $18.00 | $7.5M | Indirect | Aug 12, 2020 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Orbimed ROF II LLC's insider trades
Orbimed ROF II LLC is a 10% owner of Xtant Medical Holdings (XTNT). Since Aug 10, 2020, it has reported 2 open-market purchases worth $22.5M and 1 sale worth $30.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (4 filings), grants and awards (3 filings), conversions (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every XTNT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.